Medical Devices Startups

Totus Medicines is a biopharmaceutical company developing small molecule drugs to address untreatable diseases by combining approaches in molecular design, structural biology, genetics, and cell biology. The company focuses on oncology and other therapeutic areas for patients with currently incurable conditions.

1 investor

Touchlight manufactures enzymatic DNA for genetic medicine applications, including mRNA and DNA vaccines, viral vector production, gene therapy, and genome editing. The company operates GMP-compliant manufacturing suites using cell-free DNA technology to produce pharmaceutical-grade plasmid DNA at commercial scale.

1 investor

Tover develops serious games designed to improve quality of life for people with cognitive challenges, working in partnership with care professionals. The company focuses on creating meaningful, engaging experiences that support cognitive health and wellbeing.

1 investor

Toxometris provides AI-powered in silico toxicity predictions for pharmaceutical compounds, combining mechanistic interpretability with predictive accuracy. The platform serves medicinal chemists and toxicologists for lead optimization, regulatory submission support, and compound library screening.

1 investor

TQ Therapeutics develops cell and gene therapy technologies and processes to make challenging diseases curable. The company focuses on manufacturing and engineering advances in cell therapy for patient treatment.

1 investor

TRACER offers customized data quality services and analysis, emphasizing precision and speed to support faster decision-making for clients.

1 investor

Tracer Biotechnologies develops genomic profiling and biomarker detection solutions for oncology and cancer treatment. The company serves healthcare providers and clinical laboratories focused on precision medicine and treatment guidance.

1 investor

TracInnovations develops the Tracoline system, a markerless 3D stereo vision motion tracking and monitoring device that records patient head movements during MRI brain scans to enable prospective or retrospective motion correction. Its FDA-cleared, CE-marked products serve MRI/neurology imaging workflows and are compatible with 3T scanners from Siemens, Philips, and GE.

1 investor

TrackiMed develops an AI surgical co-pilot that uses computer vision and voice recognition to automate operating room workflows, eliminating manual instrument counting and documentation. The platform serves hospitals by reducing procedure time, improving surgical team efficiency, and preventing medical errors.

1 investor

Tradewind BioScience translates research discoveries into novel cancer therapeutics. The company develops drug therapies for cancer patients through research-driven drug discovery and development.

1 investor

Trailhead Biosystems develops HD-DoE (High-Dimensional Design-of-Experiments), a platform that uses computational models and control systems to differentiate human induced pluripotent stem cells (iPSCs) into specific cell types for regenerative medicine and stem cell research. The company serves stem cell researchers and cell-therapy developers with iPSC research products and differentiation technologies.

1 investor

TRAINFES provides neurological rehabilitation using FDA-certified electrical stimulation medical devices and a cloud platform with AI that programs personalized therapies remotely. It serves patients recovering from paralysis caused by conditions such as stroke, spinal cord injury, traumatic brain injury and cerebral palsy, delivering therapy in clinics and at home.

1 investor

Travere Therapeutics develops and delivers therapies for rare kidney and metabolic diseases, with a pipeline including potential first-in-class treatments for conditions such as classical homocystinuria and immune-mediated rare kidney diseases. The company also supports initiatives to improve diagnosis, access, and equity in rare disease care for patients and their families.

1 investor

Trears Biomarkers develops medical devices and biomarker platforms using earwax-based sampling to enable long-term monitoring of chronic conditions like metabolic syndrome and cardiovascular disease. The company operates at the intersection of clinical diagnostics and digital health, serving healthcare systems and clinical partners with non-invasive alternatives to point-in-time blood or saliva testing.

1 investor

TreeFrog develops C-Stem, a GMP-compliant technology platform for scalable production of cell therapies that optimizes yield and quality while minimizing cell damage. The platform serves biotech and cell therapy companies from early-stage research through commercial manufacturing.

1 investor

TREPLABS builds low-cost, connected medical devices and Software as a Medical Device (SaMD) applications for medical professionals and scientists. Its clinical tools combine hardware and software with internet connectivity and machine learning analysis to support disease outbreak management, drug discovery, and patient care.

1 investor

Trevena develops and commercializes innovative pharmaceutical therapies for central nervous system disorders. The company has an FDA-approved drug (OLINVYK) and multiple investigational candidates targeting migraine, opioid use disorder, and neuropathic pain.

1 investor

TriApex provides contract research organization (CRO) services supporting pharmaceutical and biologics development, including preclinical studies, clinical trial design, regulatory strategy, and post-market safety monitoring.

1 investor

Tri-Imaging sells, leases, repairs, and sources parts for medical imaging equipment, and operates an apprenticeship program for training professionals in medical imaging services. The company serves healthcare facilities seeking reliable equipment maintenance and skilled workforce development.

1 investor

Tribal Diagnostics is a Native-owned clinical laboratory that performs blood and diagnostic lab tests at low, transparent prices (e.g. $5 cholesterol, $9 CBC) for patients with or without insurance. Founded in 2016, it partners with healthcare providers including Tribal and urban Indian clinics as well as non-native clinics across the United States, and is in-network with major insurance carriers.

1 investor

TridentCare provides portable and mobile diagnostic services—including digital X-ray, ultrasound, EKG, laboratory, phlebotomy, and PICC/vascular access—delivered on-site to patients across various care settings. It serves healthcare providers and facilities nationwide in the United States, connecting customer locations through its TridentConnect EMR-integrated platform.

1 investor

TridentCare provides clinical services to elderly and post-acute patients through a combination of technology and clinical workforce. The company focuses on delivering high-quality care to high-needs populations across various care settings.

1 investor

TriFetch develops AI systems for clinical healthcare workflows, leveraging medical imaging and AI expertise to improve diagnostic and operational processes in hospitals and clinics.

1 investor

Trillium Health Care Products is a contract manufacturer of prescription and over-the-counter pharmaceutical and consumer products for North American companies, based in Brockville, Ontario. With over 50 years of experience, it manufactures a range of medications and health products while maintaining FDA and Health Canada compliance.

1 investor